Standout Papers

CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer 2022 2026 2023 2024133
  1. CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer (2022)
    Yu Zheng, Sheng Jin et al. Frontiers in Immunology

Citation Impact

1 by Nobel laureates 2 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

Recent Advances in 3D Printing of Smart Scaffolds for Bone Tissue Engineering and Regeneration
2024 Standout
CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
2 intermediate papers

Works of Junlin Yao being referenced

CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer
2022 Standout
Manipulating the air-filled zebrafish swim bladder as a neutrophilic inflammation model for acute lung injury
2016
and 1 more

Author Peers

Author Oncology Molecular Biology PRM Immunology Last Decade Papers Cites
Junlin Yao 258 531 132 301 24 1.0k
Laura J. Claxton 2 6 2 23 823
John Abeysekera 2 109 1 35 579
R. Le Cohu 73 1 45 377
Todd Murray 185 14 143 9 368
Thomas Schneider 6 31 323 9 91 2.3k

All Works

Loading papers...

Rankless by CCL
2026